Separately, the molecule recombinant human soluble thrombomodulin (rhTM) binds and antagonizes HMGB1, thus addressing elevated tissue levels of HMGB1 in preclinical NEC, and provided an anti-inflammatory impact (26). This evidence concerns the gene HMGB1 and necrotizing enterocolitis.